Expertise in
8
conditions

Dr. Karen S. Miller

Pulmonary Medicine
St Luke's Idaho Pulmonary Associates
2347 E Gala St, 
Meridian, ID 
Accepting New Patients
Expertise in
8
conditions
St Luke's Idaho Pulmonary Associates
2347 E Gala St, 
Meridian, ID 

Overview

Karen Miller is a Pulmonary Medicine provider practicing medicine in Meridian, Idaho.

Dr. Miller is highly rated in 8 conditions, according to our data. Her clinical expertise encompasses Cystic Fibrosis, Lung Metastases, Secondary Immunodeficiency (SID), Newborn Jaundice, and Tissue Biopsy.

She is actively involved in clinical research, co-authoring 4 peer reviewed articles and participating in 4 clinical trials. Dr. Miller is currently accepting new patients.

Specialties

Pulmonary Medicine

Licenses

Internal Medicine in ID

Hospital Affiliations

St Luke's Nampa Medical Center
St Luke's Regional Medical Center

Languages Spoken

English

Gender

Female

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Blue Shield of California
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE-MEDICAID PLAN
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Cambia Health Solutions
  • EPO
  • INSURANCE PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • PPO
Capital District Physicians Health
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
Change Healthcare
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
Cigna
  • EPO
  • HMO
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
LA Care
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Moda Health
  • EPO
  • PPO
PacificSource
  • PPO
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
SelectHealth
  • HMO
  • POS
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 13 Less Insurance Carriers -

Locations

St Luke's Idaho Pulmonary Associates
2347 E Gala St, Meridian, ID 83642
Other Locations
St. Luke's Regional Medical Center
190 E Bannock St, Boise, ID 83712

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Randomized, Double-Blind, Placebo Controlled Dose-Ranging Study of Auxora in Patients With Acute Pancreatitis and Accompanying Systemic Inflammatory Response Syndrome
A Randomized, Double-Blind, Placebo Controlled Dose-Ranging Study of Auxora in Patients With Acute Pancreatitis and Accompanying Systemic Inflammatory Response Syndrome
Enrollment Status: Completed
Publish Date: August 24, 2026
Intervention Type: Drug, Other
Study Drug: CM-4620 Injectable Emulsion or CM-4620-IE
Study Phase: Phase 2
A Multicenter, Open-Label, Pharmacokinetic and Safety Study of Baricitinib in Pediatric Patients From 1 Year to Less Than 18 Years Old Hospitalized With COVID-19
A Multicenter, Open-Label, Pharmacokinetic and Safety Study of Baricitinib in Pediatric Patients From 1 Year to Less Than 18 Years Old Hospitalized With COVID-19
Enrollment Status: Terminated
Publish Date: August 11, 2026
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
RESOLUTION: A Double-blind, Randomized, Placebo-controlled, Phase II/III Study of the Efficacy and Safety of LAU-7b in the Treatment of Adult Hospitalized Patients With COVID-19 Disease
RESOLUTION: A Double-blind, Randomized, Placebo-controlled, Phase II/III Study of the Efficacy and Safety of LAU-7b in the Treatment of Adult Hospitalized Patients With COVID-19 Disease
Enrollment Status: Terminated
Publish Date: November 13, 2025
Intervention Type: Drug
Study Drug: Fenretinide
Study Phase: Phase 2/Phase 3
APPLAUD: A Double-Blind, Randomized, Placebo-Controlled, Phase II Study of the Efficacy and Safety of LAU-7b in the Treatment of Cystic Fibrosis in Adults
APPLAUD: A Double-Blind, Randomized, Placebo-Controlled, Phase II Study of the Efficacy and Safety of LAU-7b in the Treatment of Cystic Fibrosis in Adults
Enrollment Status: Completed
Publish Date: October 09, 2024
Intervention Type: Drug
Study Drug: Fenretinide
Study Phase: Phase 2
View 3 Less Clinical Trials

4 Total Publications

Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype.
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype.
Journal: The New England journal of medicine
Published: April 30, 2025
Similar Doctors
Expertise in
15
conditions
Dr. N J. East
Pulmonary Medicine
Expertise in
15
conditions
Dr. N J. East
Pulmonary Medicine
Referral may be required
Before you request

Saint Alphonsus Regional Medical Center

1055 N Curtis Rd, 
Boise, ID 
 (5.8 miles away)
208-367-2121
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

N East is a Pulmonary Medicine provider practicing medicine in Boise, Idaho. Dr. East is highly rated in 15 conditions, according to our data. His clinical expertise encompasses Asthma, Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Transmyocardial Revascularization, and Stent Placement. Dr. East is currently accepting new patients.

Expertise in
11
conditions
Dr. Kathleen R. Sutherland
Pulmonary Medicine
Expertise in
11
conditions
Dr. Kathleen R. Sutherland
Pulmonary Medicine
Referral may be required

Idaho Pulmonary Associates PA

1075 N Curtis Rd Ste 200, 
Boise, ID 
 (5.7 miles away)
208-367-8333
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Kathleen Sutherland is a Pulmonary Medicine provider practicing medicine in Boise, Idaho. Dr. Sutherland is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Lung Metastases, Chronic Obstructive Pulmonary Disease (COPD), Interstitial Lung Disease, and Acute Interstitial Pneumonia. Dr. Sutherland is currently accepting new patients.

Expertise in
8
conditions
Dr. Joshua D. Holweger
Pulmonary Medicine
Expertise in
8
conditions
Dr. Joshua D. Holweger
Pulmonary Medicine
Referral may be required

Idaho Pulmonary Associates PA

1075 N Curtis Rd Ste 200, 
Boise, ID 
 (5.7 miles away)
208-367-8333
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Joshua Holweger is a Pulmonary Medicine provider practicing medicine in Boise, Idaho. Dr. Holweger is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Asthma, Grass Allergy, Lung Metastases, and Pneumonia. Dr. Holweger is currently accepting new patients.

Frequently Asked Questions about Dr. Karen S. Miller

How do I make an appointment with Dr. Karen S. Miller?

You can book an appointment with Dr. Karen S. Miller by calling their office at 208-323-3767. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Karen S. Miller a top-rated expert for Cystic Fibrosis?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Karen S. Miller is classified as an Advanced expert for Cystic Fibrosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Karen S. Miller specialize in?

While Dr. Karen S. Miller is a Pulmonary Medicine, they have specific expertise in Cystic Fibrosis, Lung Metastases, and Secondary Immunodeficiency (SID). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pulmonary Medicine.

Does Dr. Karen S. Miller participate in research or clinical trials?

Yes. Dr. Karen S. Miller has published 4 articles and abstracts on conditions like Cystic Fibrosis. You can view a list of Dr. Karen S. Miller's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Karen S. Miller accept my insurance?

Dr. Karen S. Miller accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 208-323-3767 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Miller's expertise for a condition
ConditionClose
      View All 8 Advanced Conditions
      View All 23 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile